Oticon Medical is a global hearing healthcare company specializing in bone-anchored hearing solutions (BAHS), a niche segment addressing conductive hearing loss. The company is recognized for its innovative solutions, including the newly launched Sentio, the smallest and most versatile transcutaneous implant, expected to be the main growth driver.
Global reach with sales in more than 25 countries, a c. 30% global market share and a high share of
recurring revenues from sound processor upgrades.
Previously, Oticon Medical operated as a standalone business unit of Danish audiology group Demant.
Oticon Medical facts
MedTech
March 2026
Gothenburg, Sweden
René Govaerts (CEO)
Magnus Edlund
Fredrik Strömholm
Fredrik Odin
Edvard Hubendick
Johan Kårestedt
280
Investment thesis:
- Increase availability of care by bringing bone-anchored hearing solutions to eligible patients whose needs are currently unmet
- Improve quality of care for eligible patients who currently rely on less suitable solutions (mid-ear surgery, hearing aids)
UN SDG Goals
Other portfolio companies
Oticon Medical
Oticon Medical is a global hearing healthcare company specializing in bone-anchored hearing solutions (BAHS), a niche segment addressing conductive hearing loss.
Qufora
Qufora is a fast-growing Danish medical technology product company with focus on transanal irrigation (“TAI”) products and collecting devices
Avia Pharma
Avia is a leading North European OTC/Rx platform